We use cookies

Essential storage keeps the site working (sign-in, theme, this choice). We'd also like to load Google Analytics to understand, in aggregate, how the site is used — never your genetic data. See our Cookie Policy.

HLA-DPA1 rs5025825: Genetics of Hazelnut Allergy

rs5025825
Trait
Moderate evidenceGene: HLA-DPA1

The genetic variant rs5025825 is a single nucleotide polymorphism located in the human leukocyte antigen (HLA) class II region near the HLA-DPA1 gene. Research associates this variant with susceptibility to allergic conditions, most notably secondary hazelnut allergy linked to birch pollen cross-reactivity and allergic rhinitis. Carrying specific alleles at this locus influences how the immune system presents environmental antigens to T cells.

What each genotype means

GenotypeWhat the research suggestsReading
Risk Allele HomozygoteCarrying two copies of the susceptibility allele at rs5025825 is associated with the highest relative genetic risk for secondary hazelnut allergy and pollen-associated allergic rhinitis. This genotype reflects higher population-level odds of immune cross-reactivity but does not mean an allergy is guaranteed. Clinical evaluation remains necessary to confirm active allergic symptoms.Higher attention
HeterozygoteCarrying one copy of the susceptibility allele and one non-risk allele is linked to a moderate increase in statistical risk for allergic rhinitis and secondary hazelnut sensitization compared to baseline. Most individuals with this genotype tolerate hazelnuts normally without allergic manifestations. Environmental exposures and overall immune profile play significant roles in whether symptoms occur.Informational
Non-Risk HomozygoteCarrying two copies of the baseline non-risk allele at rs5025825 is associated with standard or reduced statistical odds of secondary hazelnut allergy and allergic rhinitis in studied cohorts. While this genotype provides a favorable baseline comparison, it does not provide absolute immunity against developing pollen sensitization or dietary allergies.Favorable

Genomic Context and the HLA-DPA1 Region

The variant rs5025825 is situated on chromosome 6 in the human leukocyte antigen (HLA) class II region, adjacent to the HLA-DPA1 gene. The major histocompatibility complex (MHC) locus on chromosome 6 is one of the most gene-dense and polymorphic regions of the human genome. Genes in this cluster encode cell-surface heterodimers essential for immune surveillance. HLA-DPA1 encodes the alpha chain of the HLA-DP heterodimer, an MHC class II complex primarily expressed on professional antigen-presenting cells such as dendritic cells, B cells, and macrophages. Polymorphisms in and near HLA-DPA1 frequently modulate immune recognition, peptide-binding affinity, or transcriptional regulation of nearby HLA class II genes.

Biological Role in Immune Antigen Presentation

The primary function of the HLA class II molecular complex is to bind peptide fragments derived from extracellular proteins and display them on the cell surface for CD4+ T helper cells. When an antigen-presenting cell captures environmental proteins—such as plant pollen or food proteins—it processes them into peptides that fit into the peptide-binding groove formed by alpha and beta HLA chains. Variations within the HLA locus, including noncoding regulatory variants like rs5025825, can alter expression levels of these presentation molecules or reflect specific classical HLA alleles through linkage disequilibrium. This structural or regulatory variance shapes whether a peptide is efficiently recognized, which can bias the immune response toward a Th2-skewed allergic cascade.

Research on Hazelnut Allergy and Allergic Rhinitis

Recent large-scale genome-wide association studies (GWAS) have established rs5025825 as a top significant marker in the HLA class II region. In an adult cohort study examining food allergy genetics, rs5025825 emerged as the lead single nucleotide polymorphism associated with self-reported hazelnut allergy (p = 2.51 × 10⁻⁹, odds ratio = 1.43). The same investigation utilized Mendelian randomization to reveal a causal genetic connection between allergic rhinitis (hay fever) and secondary food allergy to hazelnuts. In secondary hazelnut allergy, individuals with primary sensitization to tree pollen—particularly birch pollen allergens such as Bet v 1—experience cross-reactive allergic reactions to homologous proteins found in hazelnuts, known as pollen food allergy syndrome.

Population Patterns and Ancestry Considerations

Genetic frequencies for HLA region markers can vary across different ancestral backgrounds due to historical pathogen selection. For rs5025825, the minor risk allele is observed at an estimated frequency of approximately 0.35 in European ancestral populations. Because the vast majority of association studies evaluating this specific polymorphism have been conducted in European cohort samples, the exact effect size, allele frequencies, and linkage patterns with specific HLA class II classical alleles in non-European ancestries remain less characterized. Additional research across diverse demographic groups is necessary to establish the universal applicability of this variant as an allergy susceptibility marker.

Translating Genetic Findings to Daily Life

Possessing risk alleles at rs5025825 does not constitute a clinical diagnosis of food allergy or hay fever. Instead, this polymorphism reflects statistical susceptibility identified in population studies. Many individuals carrying the risk allele never develop symptoms when consuming hazelnuts, whereas others without the allele may experience severe allergies. Clinical allergy diagnosis requires a thorough medical history, physical evaluation, and targeted diagnostic testing, such as skin prick tests or serum-specific IgE quantification performed under the supervision of a board-certified allergist. Genetic data cannot replace functional allergy testing and should never be used on its own to guide food avoidance or dietary elimination.

How common is this variant?

The minor allele associated with secondary hazelnut allergy has an estimated frequency of approximately 0.35 in populations of European ancestry, with limited comprehensive frequency data available across other global lineages.

Frequently asked questions

Does having the rs5025825 risk allele mean I am allergic to hazelnuts?

No, having the risk allele indicates a statistical susceptibility observed in population research, not an active medical diagnosis. Many people with the variant tolerate hazelnuts without difficulty. An allergy diagnosis requires medical history and specialized tests evaluated by an allergist.

What is the difference between primary and secondary hazelnut allergy?

Primary hazelnut allergy typically arises early in life directly against hazelnut storage proteins and can cause severe reactions. Secondary hazelnut allergy occurs when an individual first becomes sensitized to tree pollen (like birch) and later experiences mild oral itching or swelling from cross-reacting proteins in hazelnuts.

How is HLA-DPA1 related to allergic rhinitis?

HLA-DPA1 encodes part of the MHC class II molecular complex, which presents airborne allergens like pollen to the immune system. Specific variations in this genomic region can influence how readily pollen antigens are presented to T helper cells, modifying the likelihood of seasonal hay fever.

Can I use consumer genetic testing to decide if I should avoid tree nuts?

No, consumer DNA results should never be used to initiate dietary exclusions or diagnose allergies. Only formal clinical testing—such as skin prick tests, blood allergen-specific IgE panels, and physician-guided oral food challenges—can determine if an allergy exists.

Sources & further reading

Educational information only, last refreshed 9/5/2026. Not medical advice — these associations describe population statistics, not individual predictions.

Curious what your genotype is for rs5025825?

Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.

Get my report — $29